BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32935556)

  • 1. Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana.
    Koofhethile CK; Moyo S; Kotokwe KP; Chang C; Mokgethi P; Muchoba L; Mokgweetsi S; Makhema J; Lockman S; Gaseitsiwe S; de Oliveira T; Essex M; Shapiro R; Kanki P; Novitsky V
    AIDS Res Hum Retroviruses; 2021 Jan; 37(1):16-23. PubMed ID: 32935556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.
    Katusiime MG; Halvas EK; Wright I; Joseph K; Bale MJ; Kirby-McCullough B; Engelbrecht S; Shao W; Hu WS; Cotton MF; Mellors JW; Kearney MF; van Zyl GU
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.
    Rainwater-Lovett K; Ziemniak C; Watson D; Luzuriaga K; Siberry G; Petru A; Chen Y; Uprety P; McManus M; Ho YC; Lamers SL; Persaud D
    PLoS One; 2017; 12(2):e0170548. PubMed ID: 28178277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents.
    Persaud D; Patel K; Karalius B; Rainwater-Lovett K; Ziemniak C; Ellis A; Chen YH; Richman D; Siberry GK; Van Dyke RB; Burchett S; Seage GR; Luzuriaga K;
    JAMA Pediatr; 2014 Dec; 168(12):1138-46. PubMed ID: 25286283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.
    Shahid A; MacLennan S; Jones BR; Sudderuddin H; Dang Z; Cobarrubias K; Duncan MC; Kinloch NN; Dapp MJ; Archin NM; Fischl MA; Ofotokun I; Adimora A; Gange S; Aouizerat B; Kuniholm MH; Kassaye S; Mullins JI; Goldstein H; Joy JB; Anastos K; Brumme ZL;
    J Virol; 2024 Feb; 98(2):e0165523. PubMed ID: 38214547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.
    Gandhi RT; Cyktor JC; Bosch RJ; Mar H; Laird GM; Martin A; Collier AC; Riddler SA; Macatangay BJ; Rinaldo CR; Eron JJ; Siliciano JD; McMahon DK; Mellors JW;
    J Infect Dis; 2021 Feb; 223(2):225-233. PubMed ID: 32823274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4
    Jones BR; Miller RL; Kinloch NN; Tsai O; Rigsby H; Sudderuddin H; Shahid A; Ganase B; Brumme CJ; Harris M; Poon AFY; Brockman MA; Fromentin R; Chomont N; Joy JB; Brumme ZL
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31776273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
    Joseph SB; Abrahams MR; Moeser M; Tyers L; Archin NM; Council OD; Sondgeroth A; Spielvogel E; Emery A; Zhou S; Doolabh D; Ismail SD; Karim SA; Margolis DM; Pond SK; Garrett N; Swanstrom R; Williamson C
    PLoS Pathog; 2024 Feb; 20(2):e1011974. PubMed ID: 38422171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.
    McMyn NF; Varriale J; Fray EJ; Zitzmann C; MacLeod H; Lai J; Singhal A; Moskovljevic M; Garcia MA; Lopez BM; Hariharan V; Rhodehouse K; Lynn K; Tebas P; Mounzer K; Montaner LJ; Benko E; Kovacs C; Hoh R; Simonetti FR; Laird GM; Deeks SG; Ribeiro RM; Perelson AS; Siliciano RF; Siliciano JM
    J Clin Invest; 2023 Sep; 133(17):. PubMed ID: 37463049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment.
    Luzuriaga K; Tabak B; Garber M; Chen YH; Ziemniak C; McManus MM; Murray D; Strain MC; Richman DD; Chun TW; Cunningham CK; Persaud D
    J Infect Dis; 2014 Nov; 210(10):1529-38. PubMed ID: 24850788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal variation in human immunodeficiency virus long terminal repeat methylation in individuals on suppressive antiretroviral therapy.
    Cortés-Rubio CN; Salgado-Montes de Oca G; Prado-Galbarro FJ; Matías-Florentino M; Murakami-Ogasawara A; Kuri-Cervantes L; Carranco-Arenas AP; Ormsby CE; Cortés-Rubio IK; Reyes-Terán G; Ávila-Ríos S
    Clin Epigenetics; 2019 Sep; 11(1):134. PubMed ID: 31519219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical care.
    Koofhethile CK; Moyo S; Kotokwe KP; Mokgethi P; Muchoba L; Mokgweetsi S; Gaolathe T; Makhema J; Shapiro R; Lockman S; Kanki P; Essex M; Gaseitsiwe S; de Oliveira T; Novitsky V
    Medicine (Baltimore); 2019 Nov; 98(47):e18014. PubMed ID: 31764816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
    Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
    mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.
    Fokam J; Mpouel Bala ML; Santoro MM; Takou D; Tala V; Beloumou G; Ngoufack ES; Chenwi C; Pabo Willy Leroi T; Njume D; Teto G; Dambaya B; Djupsa S; Sosso S; Ateba F; Kamta C; Bala L; Njom Nlend AE; Koki Ndombo P; Colizzi V; Perno CF; Ndjolo A
    HIV Med; 2022 Jul; 23(6):629-638. PubMed ID: 34951111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune activation and exhaustion marker expression on T-cell subsets in ART-treated adolescents and young adults with perinatal HIV-1 infection as correlates of viral persistence.
    Huang Y; Dhummakupt A; Khetan P; Nilles T; Zhou W; Mudvari P; Szewczyk J; Chen YH; Boritz E; Ji H; Agwu A; Persaud D
    Front Immunol; 2023; 14():1007626. PubMed ID: 37033916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA (LoViReTs).
    Gálvez C; Urrea V; Garcia-Guerrero MDC; Bernal S; Benet S; Mothe B; Bailón L; Dalmau J; Martinez A; Nieto A; Leal L; García F; Clotet B; Martinez-Picado J; Salgado M
    J Intern Med; 2022 Aug; 292(2):308-320. PubMed ID: 35342993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa.
    Ka'e AC; Santoro MM; Duca L; Chenwi CA; Ngoufack Jagni Semengue E; Nka AD; Etame NK; Togna Pabo WL; Beloumou G; Mpouel ML; Djupsa S; Takou D; Sosso SM; Tchidjou HK; Colizzi V; Halle-Ekane GE; Perno CF; Lewin S; Jones RB; Tiemessen CT; Ceccherini-Silberstein F; Fokam J
    J Virus Erad; 2024 Mar; 10(1):100367. PubMed ID: 38601701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TZA, a Sensitive Reporter Cell-based Assay to Accurately and Rapidly Quantify Inducible, Replication-competent Latent HIV-1 from Resting CD4
    Sanyal A; Rangachar VS; Gupta P
    Bio Protoc; 2019 May; 9(10):. PubMed ID: 31428662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy.
    Peluso MJ; Bacchetti P; Ritter KD; Beg S; Lai J; Martin JN; Hunt PW; Henrich TJ; Siliciano JD; Siliciano RF; Laird GM; Deeks SG
    JCI Insight; 2020 Feb; 5(4):. PubMed ID: 32045386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved assays to measure and characterize the inducible HIV reservoir.
    Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
    EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.